Age-associated decrease in global DNA methylation in patients with major depression

Código QR

Age-associated decrease in global DNA methylation in patients with major depression

Ping-Tao Tseng,1,2,* Pao-Yen Lin,1,3,* Yu Lee,1 Chi-Fa Hung,1 For-Wey Lung,4,5 Cheng-Sheng Chen,6,7 Mian-Yoon Chong1 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 2Department of Psychiatry, Tsyr-Huey Ment...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a1c88536c1034b97b96d7cdac7fd1edc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review
por: Chen YW, et al.
Publicado: (2015)

Anxiety and depression in patients with head and neck cancer: 6-month follow-up study
por: Wu YS, et al.
Publicado: (2016)

DNA methylation evidence against the accelerated aging hypothesis of schizophrenia
por: Brandon C. McKinney, et al.
Publicado: (2017)

Association between maternal depression during pregnancy and newborn DNA methylation
por: Emily Drzymalla, et al.
Publicado: (2021)

The impact of age of onset on amygdala intrinsic connectivity in major depression
por: Clark DL, et al.
Publicado: (2018)

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients
por: Hisashi Higuchi, et al.
Publicado: (2009)

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
por: Brown EC, et al.
Publicado: (2018)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Association between toll-like receptor 4 expression and symptoms of major depressive disorder
por: Wu MK, et al.
Publicado: (2015)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

Transcranial magnetic stimulation for the treatment of major depression
por: Janicak PG, et al.
Publicado: (2015)

Use of the Hospital Anxiety and Depression Scale and the Taiwanese Depression Questionnaire for screening depression in head and neck cancer patients in Taiwan
por: Lee Y, et al.
Publicado: (2016)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
por: Dannehl K, et al.
Publicado: (2014)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013)

The cortisol awakening response and major depression: examining the evidence
por: Dedovic K, et al.
Publicado: (2015)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis GA, et al.
Publicado: (2015)

Is placebo useful in the treatment of major depression in clinical practice?
por: Marchesi C, et al.
Publicado: (2013)

Psychomotor retardation and externally oriented thinking in major depression
por: Luca M, et al.
Publicado: (2013)

DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.
por: Manabu Fuchikami, et al.
Publicado: (2011)

Acupuncture Treatment is Associated with a Decreased Risk of Dementia in Patients with Depression: A Propensity Score-Matched Cohort Study
por: Chen KY, et al.
Publicado: (2021)

Decreased Plasma Hydrogen Sulfide Level Is Associated With the Severity of Depression in Patients With Depressive Disorder
por: Yuan-Jian Yang, et al.
Publicado: (2021)

Major depressive disorder: mechanism-based prescribing for personalized medicine
por: Saltiel PF, et al.
Publicado: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang X, et al.
Publicado: (2015)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak J, et al.
Publicado: (2013)

A meta-analysis of lipid peroxidation markers in major depression
por: Mazereeuw G, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang XF, et al.
Publicado: (2015)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez E, et al.
Publicado: (2014)

METHYLATION OF CELLULAR DNA AND PATHOLOGY OF THE ORGANISM
por: V. A. Kozlov
Publicado: (2014)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Marty Hinz, et al.
Publicado: (2010)

DNA methylation in schizophrenia in different patient-derived cell types
por: Alejandra M. Vitale, et al.
Publicado: (2017)

Genome-wide DNA methylation analysis of pulmonary function in middle and old-aged Chinese monozygotic twins
por: Tong Wang, et al.
Publicado: (2021)

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
por: Armaly Z, et al.
Publicado: (2012)

Getting the balance right: Established and emerging therapies for major depressive disorders
por: Bojana Perovic, et al.
Publicado: (2010)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
por: Pecenak J, et al.
Publicado: (2013)

Blood-based mitochondrial respiratory chain function in major depression
por: Johan Fernström, et al.
Publicado: (2021)

Estimation of chimpanzee age based on DNA methylation
por: Hideyuki Ito, et al.
Publicado: (2018)

A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
por: Ha-Neui Kim, et al.
Publicado: (2021)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen JJ, et al.
Publicado: (2018)